IL44329A - 1,4-dihydroquinoline derivatives their production and pharmaceutical compositions containing them - Google Patents

1,4-dihydroquinoline derivatives their production and pharmaceutical compositions containing them

Info

Publication number
IL44329A
IL44329A IL44329A IL4432974A IL44329A IL 44329 A IL44329 A IL 44329A IL 44329 A IL44329 A IL 44329A IL 4432974 A IL4432974 A IL 4432974A IL 44329 A IL44329 A IL 44329A
Authority
IL
Israel
Prior art keywords
compound
admixture
diluent
medicament
formula
Prior art date
Application number
IL44329A
Other languages
English (en)
Other versions
IL44329A0 (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL44329A0 publication Critical patent/IL44329A0/xx
Publication of IL44329A publication Critical patent/IL44329A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/06—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
IL44329A 1973-03-03 1974-03-01 1,4-dihydroquinoline derivatives their production and pharmaceutical compositions containing them IL44329A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732310746 DE2310746A1 (de) 1973-03-03 1973-03-03 Verfahren zur herstellung von neuen 1,4-dihydrochinolinen sowie ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
IL44329A0 IL44329A0 (en) 1974-06-30
IL44329A true IL44329A (en) 1977-08-31

Family

ID=5873779

Family Applications (1)

Application Number Title Priority Date Filing Date
IL44329A IL44329A (en) 1973-03-03 1974-03-01 1,4-dihydroquinoline derivatives their production and pharmaceutical compositions containing them

Country Status (21)

Country Link
US (1) US3910917A (sv)
JP (1) JPS49134685A (sv)
AT (1) AT328452B (sv)
AU (1) AU473590B2 (sv)
BE (1) BE811688A (sv)
CA (1) CA1024517A (sv)
CH (1) CH597191A5 (sv)
DD (1) DD113002A5 (sv)
DE (1) DE2310746A1 (sv)
DK (1) DK137924C (sv)
ES (1) ES423716A1 (sv)
FR (1) FR2219786B1 (sv)
GB (1) GB1421305A (sv)
HU (1) HU167415B (sv)
IE (1) IE39049B1 (sv)
IL (1) IL44329A (sv)
LU (1) LU69530A1 (sv)
NL (1) NL7402750A (sv)
PL (1) PL88760B1 (sv)
SE (1) SE403285B (sv)
ZA (1) ZA741353B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6210087A (ja) * 1985-07-03 1987-01-19 Shionogi & Co Ltd ４，７−ジヒドロチエノ〔２，３−ｂ〕ピリジン誘導体，その製造法および循環器系疾患治療剤
FR2801310B1 (fr) * 1999-11-24 2004-04-16 Adir NOUVEAUX DERIVES DE DIHYDROFURO-[3,4-b]QUINOLEIN-1-ONES, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT
WO2009112791A1 (en) * 2008-03-14 2009-09-17 Assaymetrics Limited Fluorogenic peptides and their method of production
US11511900B2 (en) 2021-03-18 2022-11-29 Osgood Industries, Llc Adjustable frame mount for process unit

Also Published As

Publication number Publication date
GB1421305A (en) 1976-01-14
FR2219786B1 (sv) 1977-11-10
US3910917A (en) 1975-10-07
DD113002A5 (sv) 1975-05-12
JPS49134685A (sv) 1974-12-25
ES423716A1 (es) 1976-04-01
BE811688A (fr) 1974-08-28
CA1024517A (en) 1978-01-17
PL88760B1 (sv) 1976-09-30
LU69530A1 (sv) 1974-10-09
AU6597374A (en) 1975-08-28
DK137924C (da) 1978-10-30
AU473590B2 (en) 1976-06-24
HU167415B (en) 1976-04-28
DE2310746A1 (de) 1974-09-12
ATA173474A (de) 1975-06-15
IE39049B1 (en) 1978-07-19
AT328452B (de) 1976-03-25
ZA741353B (en) 1975-01-29
NL7402750A (sv) 1974-09-05
SE403285B (sv) 1978-08-07
FR2219786A1 (sv) 1974-09-27
IE39049L (en) 1974-09-03
CH597191A5 (sv) 1978-03-31
IL44329A0 (en) 1974-06-30
DK137924B (da) 1978-06-05

Similar Documents

Publication Publication Date Title
IE50504B1 (en) Optically active 1,4-dihydropyridine compounds,their production and their medicinal use
US4285955A (en) 1,4-Dihydropyridinecarboxylic acids
US4551467A (en) Vasodilating cyanoalkyl esters of 1,4-dihydropyridines
US4248873A (en) Nitro-substituted 1,4-dihydropyridines, processes for _their production and their medicinal use
US4380547A (en) Dihydropyridine compounds which are substituted in the 4-position by imidazolyl or thiazolyl and their medicinal use
IL41668A (en) N-Transformed History of Dihydropyridine, Their Manufacture, and Pharmaceutical Preparations Containing Them
IE51651B1 (en) Cerebral therapeutic agent and its use
GB1585978A (en) Dihydropyridine compounds their production and their medicinal use
US4256749A (en) Fluorine-containing 1,4-dihydropyridine compounds, pharmaceutical compositions thereof and their medicinal use
EP0892796B1 (en) Isatin derivatives as acetylcholinesterase inhibitors and analgesics
US4483985A (en) Production of 1,4-dihydropyridinecarboxylic acids
US4146627A (en) Aminoalkylideamino-1,4-dihydropyridines and their use as medicaments
US5411955A (en) Thiadiazinecarboxamide derivatives, processes for their preparation and pharmaceuticals
IL44329A (en) 1,4-dihydroquinoline derivatives their production and pharmaceutical compositions containing them
US4187306A (en) Benzodiazepine-diones, a process for their production and their use as medicaments
IL42933A (en) 2- Alcalamino dihydropyridines, their manufacture and pharmaceutical preparations containing them
US4162321A (en) Sulphur-containing amino-dihydropyridines, and their use as medicants
IL46593A (en) 2-amino-6-dialkylamino-dihydropyridines their production and pharmaceutical compositions containing them
US4166855A (en) 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ester, and its use as a peripheral vasodilator
AU596927B2 (en) Pyrido (1,8) naphthyridinones and their use as pharmaceuticals
US4469696A (en) Substituted 2-amino-pyridine derivative compounds, their production and their medicinal use
IL43080A (en) 3,4-dihydropyridones,their production and pharmaceutical compositions containing them
US4364952A (en) Certain 1,4-dihydro-2,6-dimethyl-3,5-pyridine-dicarboxylates, composition containing same and method of use
IL44330A (en) 2-amino-3,4-dihydropyridines their production and pharmaceutical compositions containing them
CA1181402A (en) Substituted 2-amino-3,4-dihydropyridine derivatives, their production and their medicinal use